Chapter 6. Cognitive Phenotypes in ASD

Almeida LE et al., 2014. Increased BDNF expression in fetal brain in the valproic acid model of autism. Mol Cell Neurosci. 59:57-62. doi: 10.1016/j.mcn.2014.01.007.

Ameis et al., 2016. A diffusion tensor imaging study in children with ADHD, autism spectrum disorder, OCD, and matched controls: distinct and non-distinct white matter disruption and dimensional brain-behavior relationships. Am J Psychiatry. 2016 Jul 1:appiajp201615111435.

Bölte S et al., 2009. Brief report: The level and nature of autistic intelligence revisited. J Autism Dev Disord. 39(4):678-82. doi: 10.1007/s10803-008-0667-2.

Bortolato M et al., 2013. Monoamine oxidase A and A/B knockout mice display autistic-like features. Int J Neuropsychopharmacol. 16(4):869-88. doi: 10.1017/S1461145712000715.

Bortolato M et al., 2013. Early postnatal inhibition of serotonin synthesis results in long-term reductions of perseverative behaviors, but not aggression, in MAO A-deficient mice. Neuropharmacology. 75:223-32. doi: 10.1016/j.neuropharm.2013.07.003.

Bryn V et al., 2015. Brain derived neurotrophic factor (BDNF) and autism spectrum disorders (ASD) in childhood. Eur J Paediatr Neurol. 19(4):411-4. doi: 10.1016/j.ejpn.2015.03.005.

Calabrese F et al., 2013. Lack of serotonin transporter alters BDNF expression in the rat brain during early postnatal development. Mol Neurobiol. 48(1):244-56. doi: 10.1007/s12035-013-8449-z.

Chien WH et al., 2013. Increased gene expression of FOXP1 in patients with autism spectrum disorders. Mol Autism. 4(1):23. doi: 10.1186/2040-2392-4-23.

Cirulli ET et al., 2010. Common genetic variation and performance on standardized cognitive tests. Eur J Hum Genet. 18(7):815-20. doi: 10.1038/ejhg.2010.2.

Davies G et al., 2011. Genome-wide association studies establish that human intelligence is highly heritable and polygenic. Mol Psychiatry. 16(10):996-1005. doi: 10.1038/mp.2011.85.

Davis LK et al., 2008. Cortical enlargement in autism is associated with a functional VNTR in the monoamine oxidase A gene. Am J Med Genet B Neuropsychiatr Genet. 147B(7):1145-51. doi: 10.1002/ajmg.b.30738.

Dawson M et al., 2007. The level and nature of autistic intelligence. Psychol Sci. 18(8):657-62.

Fombonne E. 2006. Past and future perspectives on autism epidemiology. pp 25–48 in: Understanding Autism, from Basic Neuroscience to Treatment. Taylor & Francis, New York, USA.

Halepoto DM et al., 2014. Possible role of brain-derived neurotrophic factor (BDNF) in autism spectrum disorder: current status. J Coll Physicians Surg Pak. 24(4):274-8. doi: 04.2014/JCPSP.274278.

Hill WD et al., 2014. Human cognitive ability is influenced by genetic variation in components of postsynaptic signalling complexes assembled by NMDA receptors and MAGUK proteins. Transl Psychiatry. 4:e341. doi: 10.1038/tp.2013.114.

Hranilović D et al., 2009. Hyperserotonemia in autism: activity of 5HT-associated platelet proteins. J Neural Transm (Vienna). 116(4):493-501. doi: 10.1007/s00702-009-0192-2.

Iossifov I. 2015. Low load for disruptive mutations in autism genes and their biased transmission. Proc Natl Acad Sci U S A. 112(41):E5600-7. doi: 10.1073/pnas.1516376112.

Iuculano T et al., 2014. Brain organization underlying superior mathematical abilities in children with autism. Biol Psychiatry 75: 223–230.

Kasarpalkar NJ et al., 2014. Brain-derived neurotrophic factor in children with autism spectrum disorder. Ann Neurosci. 21(4):129-33. doi: 10.5214/ans.0972.7531.210403.

Kashevarova AA et al., 2014. Single gene microdeletions and microduplication of 3p26.3 in three unrelated families: CNTN6 as a new candidate gene for intellectual disability. Mol Cytogenet. 7(1):97. doi: 10.1186/s13039-014-0097-0.

Kim SJ et al., 2002. Transmission disequilibrium mapping at the serotonin transporter gene (SLC6A4) region in autistic disorder. Mol Psychiatry. 7(3):278-88.

Kolevzon A et al., 2014. Self-injury in autism spectrum disorder: an effect of serotonin transporter gene promoter variants. Psychiatry Res. 220(3):987-90.

Loke YJ et al., 2015. The role of epigenetic change in autism spectrum disorders. Front Neurol. 6:107. doi: 10.3389/fneur.2015.00107.

MacFarlane PM et al., 2015. Microglia modulate brainstem serotonergic expression following neonatal sustained hypoxia exposure: implications for Sudden Infant Death Syndrome. J Physiol. Dec 12. doi: 10.1113/JP271845.

Mercado E 3rd et al., 2015. Heterogeneity in perceptual category learning by high functioning children with autism spectrum disorder. Front Integr Neurosci. 9:42. doi: 10.3389/fnint.2015.00042.

McLean RL et al., 2014. Executive function in probands with autism with average IQ and their unaffected first-degree relatives. J Am Acad Child Adolesc Psychiatry53(9):1001-9. doi: 10.1016/j.jaac.2014.05.019.

Najmabadi H et al., 2011. Deep sequencing reveals 50 novel genes for recessive cognitive disorders. Nature. 478(7367):57-63. doi: 10.1038/nature10423.

O’Roak BJ et al., 2011. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet 43: 585–589.

Plomin R et al., 2013. Common DNA markers can account for more than half of the genetic influence on cognitive abilities. Psychol Sci. 24(4):562-8. doi: 10.1177/0956797612457952.

Roohi, J et al., 2009. Association of a monoamine oxidase-a gene promoter polymorphism with ADHD and anxiety in boys with autism spectrum disorder. J Autism Dev Disord. 39(1):67-74. doi: 10.1007/s10803-008-0600-8.

Ronemus M et al., 2014. The role of de novo mutations in the genetics of autism spectrum disorders. Nat Rev Genet. 15(2):133-41. doi: 10.1038/nrg3585.

Rosenthal M et al., 2013. Impairments in real-world executive function increase from childhood to adolescence in autism spectrum disorders. Neuropsychology. 27(1):13-8. doi: 10.1037/a0031299.

Sanders SJ et al., 2015. Insights into Autism Spectrum disorder genomic architecture and biology from 71 risk loci. Neuron. 87(6):1215-33. doi: 10.1016/j.neuron.2015.09.016.

Schanen NC. 2006. Epigenetics of autism spectrum disorders. Hum Mol Genet. 15 Spec No 2:R138-50.

Scott-Van Zeeland, AA, et al., 2010. Altered functional connectivity in frontal lobe circuits is associated with variation in the autism risk gene CNTNAP2. Sci Transl Med 2(56): 56ra80. doi: 10.1126/scitranslmed.3001344

Sinha P et al., 2014. Autism as a disorder of prediction. Proc Natl Acad Sci U S A. 111(42):15220-5. doi: 10.1073/pnas.1416797111.

Tassone F et al., MAOA, DBH and SLC6A4 variants in CHARGE: a case-control study of autism spectrum disorders. Autism Res. 4(4):250-61. doi: 10.1002/aur.196.

Turi M et al., 2015. Children with autism spectrum disorder show reduced adaptation to number. Proc Natl Acad Sci U S A. 112(25):7868-72. doi: 10.1073/pnas.1504099112.

Tsai SJ. 1995. Is autism caused by early hyperactivity of brain-derived neurotrophic factor? Med Hypotheses 65(1):79-82.

Valenti D et al., 2014. Mitochondrial dysfunction as a central actor in intellectual disability-related diseases: an overview of Down syndrome, autism, Fragile X and Rett syndrome. Neurosci Biobehav Rev. 46 Pt 2:202-17. doi: 10.1016/j.neubiorev.2014.01.012.

Wang M 2015. Increased serum levels of brain-derived neurotrophic factor in autism spectrum disorder. Neuroreport. 26(11):638-41. doi: 10.1097/WNR.0000000000000404.

Wiggins JL et al., 2014. Serotonin transporter genotype impacts amygdala habituation in youth with autism spectrum disorders. Soc Cogn Affect Neurosci9(6):832-8. doi: 10.1093/scan/nst039.

Yirmiya N et al., 2002. Family-based and population study of a functional promoter-region monoamine oxidase A polymorphism in autism: possible association with IQ. Am J Med Genet. 114(3):284-7.